GSK PLC's ticker is and the CUSIP is 37733W204. A total of 880 filers reported holding GSK PLC in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $239,817 | -10.2% | 6,229 | 0.0% | 0.10% | -13.5% |
| Q1 2024 | $267,037 | +14.9% | 6,229 | -0.6% | 0.11% | +6.7% |
| Q4 2023 | $232,329 | +2.9% | 6,269 | +0.6% | 0.10% | -8.8% |
| Q3 2023 | $225,801 | +1.7% | 6,229 | 0.0% | 0.11% | +3.6% |
| Q2 2023 | $222,002 | -0.6% | 6,229 | -0.7% | 0.11% | -9.1% |
| Q1 2023 | $223,300 | +11.6% | 6,276 | +10.2% | 0.12% | -38.6% |
| Q4 2022 | $200,087 | – | 5,694 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 12,340,190 | $457,759 | 41.36% |
| Eversept Partners, LP | 2,972,954 | $110,177,675 | 9.68% |
| Soleus Capital Management, L.P. | 1,278,540 | $47,382,692 | 5.26% |
| CANTOR FITZGERALD, L. P. | 638,657 | $23,668,628 | 4.86% |
| Sio Capital Management, LLC | 571,391 | $21,175,750 | 4.82% |
| Callodine Capital Management, LP | 450,000 | $16,677,000 | 4.39% |
| EQUITY INVESTMENT CORP | 3,243,259 | $120,195,186 | 3.38% |
| Clean Yield Group | 213,431 | $7,909,753 | 3.33% |
| Robinson Value Management, Ltd. | 128,079 | $4,746,608 | 3.12% |
| Hillman Capital Management, Inc. | 233,386 | $8,649,285 | 2.99% |